TAMGIBLIMAB
UNII U4GWM84S22

Substance Identification & Data

This profile provides standardized clinical and technical data for Tamgiblimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U4GWM84S22.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2411914-36-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

U4GWM84S22

CAS Registry Number

2411914-36-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TAMGIBLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C176872

National Cancer Institute reference terminology for clinical and research data.

INN ID

11690

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tamgiblimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TAMGIBLIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G4 (230-PROLINE,236-ALANINE,237-ALANINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN RECEPTOR TIGIT) (HUMAN MONOCLONAL IBI939 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL IBI939 .KAPPA.-CHAIN, DIMER

TAMGIBLIMAB [INN]

TAMGIBLIMAB [WHO-DD]